MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Fospropofol.
Acepromazine
The risk or severity of adverse effects can be increased when Acepromazine is combined with Fospropofol.
Aceprometazine
The risk or severity of adverse effects can be increased when Aceprometazine is combined with Fospropofol.
Alfaxalone
The risk or severity of adverse effects can be increased when Fospropofol is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Fospropofol.
Alphaprodine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Fospropofol.
Amisulpride
The risk or severity of adverse effects can be increased when Amisulpride is combined with Fospropofol.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fospropofol.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Fospropofol.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Fospropofol.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Fospropofol.
Articaine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Fospropofol.
Azelastine
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Fospropofol.
Barbital
The risk or severity of adverse effects can be increased when Barbital is combined with Fospropofol.
Benoxinate
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fospropofol.
Benperidol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Benzocaine is combined with Fospropofol.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Benzyl alcohol.
Brexpiprazole
The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Fospropofol.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Fospropofol.
Bromperidol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Fospropofol.
Brotizolam
The risk or severity of adverse effects can be increased when Fospropofol is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Fospropofol.
Buprenorphine
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Fospropofol.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Fospropofol.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Fospropofol.
Butamben
The risk or severity of adverse effects can be increased when Fospropofol is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Butethal is combined with Fospropofol.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fospropofol.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fospropofol.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Fospropofol.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Fospropofol.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Fospropofol.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Fospropofol.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Fospropofol.
Chlormethiazole
The risk or severity of adverse effects can be increased when clomethiazole is combined with Fospropofol.
Chlormezanone
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Fospropofol.
Chloroprocaine
The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Fospropofol.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Fospropofol.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Fospropofol.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Fospropofol.
Chlorprothixene
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Fospropofol.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Fospropofol.
Citalopram
The risk or severity of adverse effects can be increased when Fospropofol is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Fospropofol.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Fospropofol.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Fospropofol.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Fospropofol.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Fospropofol.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Fospropofol.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Fospropofol.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Fospropofol.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Fospropofol.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Fospropofol.
Cocaine
The risk or severity of adverse effects can be increased when Cocaine is combined with Fospropofol.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Fospropofol.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Fospropofol.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Fospropofol.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Fospropofol.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Fospropofol.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Fospropofol.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Fospropofol.
Dapiprazole
The risk or severity of adverse effects can be increased when Dapiprazole is combined with Fospropofol.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Fospropofol.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Fospropofol.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Fospropofol.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of sedation and somnolence can be increased when Fospropofol is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fospropofol.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Fospropofol.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Fospropofol.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Fospropofol.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Fospropofol.
Dibucaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Fospropofol.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Fospropofol.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Fospropofol.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Fospropofol.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Fospropofol.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Fospropofol.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Fospropofol.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Duloxetine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Dyclonine is combined with Fospropofol.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Fospropofol.
Enflurane
The risk or severity of adverse effects can be increased when Enflurane is combined with Fospropofol.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Fospropofol.
Escitalopram
The risk or severity of adverse effects can be increased when Fospropofol is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Fospropofol.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fospropofol.
Ethanol
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Fospropofol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Fospropofol.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Fospropofol.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Fospropofol is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Fospropofol.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Fospropofol.
Etidocaine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Etomidate is combined with Fospropofol.
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Fospropofol.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Fospropofol.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Fospropofol.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Fospropofol.
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Fospropofol.
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Fospropofol.
Flunitrazepam
The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Fospropofol.
Fluoxetine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Fospropofol.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fospropofol.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Fospropofol.
Fluspirilene
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Fospropofol.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Fospropofol.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Fospropofol.
Fosphenytoin
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Fospropofol.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Fospropofol.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Fospropofol.
Glutethimide
The risk or severity of adverse effects can be increased when Glutethimide is combined with Fospropofol.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Fospropofol.
Halazepam
The risk or severity of adverse effects can be increased when Halazepam is combined with Fospropofol.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Fospropofol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Fospropofol.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Fospropofol.
Hexobarbital
The risk or severity of adverse effects can be increased when Hexobarbital is combined with Fospropofol.
Hydrocodone
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fospropofol.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Iloperidone
The risk or severity of adverse effects can be increased when Iloperidone is combined with Fospropofol.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Fospropofol.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Fospropofol.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Fospropofol.
Ketazolam
The risk or severity of adverse effects can be increased when Ketazolam is combined with Fospropofol.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Fospropofol.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Fospropofol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Fospropofol.
Levocabastine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Fospropofol.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Fospropofol.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Fospropofol.
Levomilnacipran
The risk or severity of adverse effects can be increased when Fospropofol is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Fospropofol.
Lidocaine
The risk or severity of adverse effects can be increased when Lidocaine is combined with Fospropofol.
Lithium
The risk or severity of adverse effects can be increased when Lithium is combined with Fospropofol.
Lithium Cation
The risk or severity of adverse effects can be increased when Lithium is combined with Fospropofol.
Lofexidine
The therapeutic efficacy of Fospropofol can be increased when used in combination with Lofexidine.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Fospropofol.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Fospropofol.
Lormetazepam
The risk or severity of adverse effects can be increased when Fospropofol is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Fospropofol.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Fospropofol.
Magnesium Sulfate
The therapeutic efficacy of Fospropofol can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Fospropofol can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Fospropofol.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Fospropofol.
Melatonin
The risk or severity of adverse effects can be increased when Melatonin is combined with Fospropofol.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Fospropofol.
Mephobarbital
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Fospropofol.
Mepivacaine
The risk or severity of adverse effects can be increased when Mepivacaine is combined with Fospropofol.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Fospropofol.
Mesoridazine
The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fospropofol.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Fospropofol.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Fospropofol.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Fospropofol.
Methapyrilene
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Fospropofol.
Methaqualone
The risk or severity of adverse effects can be increased when Methaqualone is combined with Fospropofol.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Fospropofol.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Fospropofol.
Methotrimeprazine
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Fospropofol.
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Fospropofol.
Metylperon
The risk or severity of adverse effects can be increased when Fospropofol is combined with Melperone.
Metyrosine
Fospropofol may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Fospropofol.
Milnacipran
The risk or severity of adverse effects can be increased when Fospropofol is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Mirtazapine
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Molindone is combined with Fospropofol.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Fospropofol.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Fospropofol.
Nefazodone
The risk or severity of adverse effects can be increased when Fospropofol is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Fospropofol.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Fospropofol.
Nordazepam
The risk or severity of adverse effects can be increased when Fospropofol is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Fospropofol is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Fospropofol is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Fospropofol.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Fospropofol.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Fospropofol.
Ondansetron
The risk or severity of adverse effects can be increased when Ondansetron is combined with Fospropofol.
Opium
The risk or severity of adverse effects can be increased when Fospropofol is combined with Opium.
Orphenadrine
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Fospropofol.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Fospropofol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Fospropofol.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Fospropofol.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Fospropofol.
Paraldehyde
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Fospropofol.
Paroxetine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Fospropofol.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Fospropofol.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Perazine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Fospropofol.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Fospropofol.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Phenoxyethanol.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Fospropofol.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Fospropofol.
Pipamperone
The risk or severity of adverse effects can be increased when Fospropofol is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Fospropofol.
Pirinitramide
The risk or severity of adverse effects can be increased when Fospropofol is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Pizotifen is combined with Fospropofol.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Fospropofol.
Pramipexole
Fospropofol may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Prazepam is combined with Fospropofol.
Pregabalin
The therapeutic efficacy of Fospropofol can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Prilocaine is combined with Fospropofol.
Primidone
The risk or severity of adverse effects can be increased when Primidone is combined with Fospropofol.
Procaine
The risk or severity of adverse effects can be increased when Procaine is combined with Fospropofol.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fospropofol.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Fospropofol.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Fospropofol.
Proparacaine
The risk or severity of adverse effects can be increased when Proparacaine is combined with Fospropofol.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Fospropofol.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Fospropofol.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Fospropofol.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Fospropofol.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Fospropofol.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Fospropofol.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Fospropofol.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fospropofol.
Remoxipride
The risk or severity of adverse effects can be increased when Remoxipride is combined with Fospropofol.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Fospropofol.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Fospropofol.
Ropinirole
Fospropofol may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fospropofol.
Rotigotine
Fospropofol may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Fospropofol.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Fospropofol.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Fospropofol.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Fospropofol.
Sertindole
The risk or severity of adverse effects can be increased when Sertindole is combined with Fospropofol.
Sertraline
The risk or severity of adverse effects can be increased when Fospropofol is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Fospropofol.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Fospropofol.
Sulpiride
The risk or severity of adverse effects can be increased when Sulpiride is combined with Fospropofol.
Suvorexant
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Fospropofol.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Fospropofol.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Fospropofol.
Tetracaine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Fospropofol is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Thalidomide
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Thiamylal is combined with Fospropofol.
Thiopental
The risk or severity of adverse effects can be increased when Thiopental is combined with Fospropofol.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Thiopental is combined with Fospropofol.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Fospropofol.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Fospropofol.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Fospropofol.
Tiapride
The risk or severity of adverse effects can be increased when Fospropofol is combined with Tiapride.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Fospropofol.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Fospropofol.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Fospropofol.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Fospropofol.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Fospropofol.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Fospropofol.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Fospropofol.
Triazulenone
The risk or severity of adverse effects can be increased when Fospropofol is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fospropofol.
Triflupromazine
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Fospropofol.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Fospropofol.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Fospropofol.
Urethane
The risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Fospropofol.
Valproate
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Fospropofol.
Valproic Acid
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Fospropofol.
Venlafaxine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Fospropofol.
Vortioxetine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Fospropofol.
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Fospropofol.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Fospropofol.
Zolpidem
Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Fospropofol.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Fospropofol.
Zotepine
The risk or severity of adverse effects can be increased when Fospropofol is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Fospropofol.
